Cost-Effectiveness of Colorectal Cancer Screening in the Average Risk Population

被引：34
|
作者：
Moshe Leshno
Zamir Halpern
Nadir Arber
机构：
[1] Tel Aviv University,Faculty of Management and Sackler Faculty of Medicine
[2] Tel Aviv University,Department of Gastroenterology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine
来源：
Health Care Management Science | 2003年 / 6卷 / 3期
关键词：
carcinoma of colon and rectum; screening; cost-effectiveness analysis; partially observed Markov decision process;
D O I：
10.1023/A:1024488007043
中图分类号：
学科分类号：
摘要：
Colorectal cancer (CRC) is a leading cause of cancer death in North America and in Israel. Risk of CRC increases exponentially with age starting at the age of 50 years. Therefore, people older than 50 years are being considered as an average risk population for CRC. The objective of this study was to obtain an improved assessment of the cost-effectiveness analysis of screening for CRC in the average risk population by using a more accurate technique, namely the Partially Observed Markov Decision Process (POMDP). We conducted a cost-effectiveness analysis within the specific probability rates and costs in Israel.
引用
收藏
页码：165 / 174
页数：9
相关论文
共 50 条
  • [41] Re: Improving the cost-effectiveness of colorectal cancer screening
    Loeve, F
    Brown, ML
    Boer, R
    Habbema, JDF
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (20) : 1691 - 1692
  • [42] Cost-effectiveness of screening for colorectal cancer: A simulation model
    Neilson, AR
    Whynes, DK
    IMA JOURNAL OF MATHEMATICS APPLIED IN MEDICINE AND BIOLOGY, 1995, 12 (3-4): : 355 - 367
  • [43] Colonoscopy colorectal cancer screening: Cost-effectiveness in Thailand
    Joob, Beuy
    Wiwanitkit, Viroj
    SOUTH ASIAN JOURNAL OF CANCER, 2016, 5 (01) : 19 - 19
  • [44] COST-EFFECTIVENESS OF COLORECTAL-CANCER SCREENING IN JAPAN
    SHIMBO, T
    GLICK, H
    EISENBERG, JM
    MEDICAL DECISION MAKING, 1991, 11 (04) : 326 - 326
  • [45] Cost-effectiveness of population-wide genomic screening for Lynch Syndrome and polygenic risk scores to inform colorectal cancer screening
    Jiang, Shangqing
    Guzauskas, Gregory F.
    Garbett, Shawn
    Graves, John A.
    Williams, Marc S.
    Hao, Jing
    Zhu, Jinyi
    Jarvik, Gail P.
    Carlson, Josh J.
    Peterson, Josh F.
    Veenstra, David L.
    GENETICS IN MEDICINE, 2025, 27 (02)
  • [46] Effectiveness and cost-effectiveness of colorectal cancer screening: Selecting the ideal strategy
    Bond, JH
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 : S252 - S256
  • [47] COST-EFFECTIVENESS OF BREAST CANCER SCREENING IN THE DIALYSIS POPULATION
    Wong, G.
    Howard, K.
    Craig, J.
    Chapman, J.
    NEPHROLOGY, 2007, 12 : A19 - A20
  • [48] COST-EFFECTIVENESS OF CRC FRENCH SCREENING PROGRAMME FOR AVERAGE RISK INDIVIDUALS
    Leleu, H.
    Vimont, A.
    Barre, S.
    Taleb, S.
    de Bels, F.
    VALUE IN HEALTH, 2019, 22 : S469 - S469
  • [49] Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History
    Cenin, Dayna R.
    Naber, Steffie K.
    de Weerdt, Anne C.
    Jenkins, Mark A.
    Preen, David B.
    Hooi, C. Ee
    O'Leary, Peter C.
    Lansdorp-Vogelaar, Iris
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (01) : 10 - 21
  • [50] Cost-effectiveness of risk-tailored screening strategy for colorectal cancer: A systematic review
    Wang, Le
    Liu, Chengcheng
    Wang, Youqing
    Du, Lingbin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (07) : 1235 - 1243
12345